Some 150 practices currently use Vidivet, which was set up by Ben Sweeney MRCVS (pictured) in 2020.
He said: “I started VidiVet as I wanted people to be able to access high quality, impartial care for their pets that allows them to make more informed decisions around their treatment with expert information, rather than resorting to the internet.
"As a vet I also wanted to make life easier for those working within veterinary practices.
"VidiVet relieves part of the burden veterinary practices face by offering a trusted digital triage service for their clients.
"Our digital service can provide a helpful extension to a practice which dramatically reduces admin and saves time for the in-house team.
"Crucially, we offer peace of mind and reduce anxiety for pet owners, and with over 96% of VidiVet out of hours calls redirected to the pet owner’s registered vet, it can really enhance the practice bond by using digital care to augment physical care."
Before the Provet partnership, OOH case notes were sent to client practices which then had to enter them onto their systems manually.
Vidivet says the intregration with Provet means less admin and time savings for practices and a quicker follow up for pet owners.
https://vidivet.com
https://www.provet.cloud
The company, which was founded by scientists from the human field, managed to raise £8 million of Series A funding by February this year. It is now seeking further investment for an extension to that Series A funding by the autumn.
The company's Chief Scientific Officer is Professor Allan Bradley, Emeritus Director of the Wellcome Trust Sanger Institute and a Fellow of the Royal Society (pictured right). He spearheaded the development of mouse transgenics and their translational use, which provided the basis for developing canine monoclonal antibody therapies.
Allan said: "We are growing a world-class scientific team that will enable PetMedix to become a global leader in the development of novel monoclonal antibody therapies for the expanding animal health market. In the short lifetime of the company we have attracted huge talent in both our scientists and executives, and moved into the heart of the Cambridge biotech sphere with its excellent facilities and networking opportunities. The recent appointment of Dr. Fabian Kausche to the board marks our intent to become a global leader in animal health."
CEO, Dr. Tom Weaver added: "We have the people and the technology in place, and are champing at the bit to progress these therapies to reach the pets that could benefit. We know this technology has transformed the treatment and survival of human patients with a variety of conditions and we want to create the same paradigm shift in veterinary treatment options to improve welfare, quality of life and longevity for our dogs and cats."
PetMedix says it is interested in hearing from potential investment partners, and mergers and acquisitions. Contact Jolyon Martin via email: jolyon.martin@PetMedix.co.uk or telephone: +44 (0) 1223 734140,
Sarah, who is one of twelve recognised Specialists in feline medicine working in the UK, will advise and explore the tell-tale signs of feline diabetes mellitus and how the condition is best managed.
Royal Canin says diabetes mellitus is estimated to affect around 1 in 200 cats and is the second most common endocrinopathy after hyperthyroidism. Risk factors can include gender and neuter status, lifestyle and medication history and most relevant today, obesity.
Sarah said: "The prevalence of feline diabetes mellitus is thought to be on the increase and diagnosis can be made more challenging by the stress hyperglycaemia phenomenon that cats are vulnerable to.
"By exploring and dissecting successful strategies and ways in which diabetic remission can be achieved, this webinar will hopefully assist veterinary professionals how to diagnose and manage effectively with great end results for both owner and cat."
To register for the webinar, visit: https://vetportal.royalcanin.co.uk/cpd/webinar/
The range includes a spray, collars and diffusers.
Unlike many other pheromone diffusers which need to be plugged into a wall socket, Virbac's uses a patent-pending slow release technology which doesn't need power.
Virbac says the new range has been scientifically proven with published studies which demonstrate not only their effectiveness in managing stress-related behaviours in dogs and cats, but also an equivalent and superior efficacy to the current market leading pheromone products 1,2,3
Andrew Connolly, Virbac's Marketing Director for the UK and Ireland said: "Veterinary professionals have a crucial role to play in supporting their clients with the behavioural management of their pets, both when visiting the practice and at home, and the benefits of pheromones in helping to manage dog and cat behaviour are already very well recognised."
"With Zenidog and Zenifel we hope to make pheromone therapy easier, more cost-effective and better for the environment."
Zenidog and Zenifel are available to order from NVS, Covetrus and VSSCo now.
References
Eurovet Animal Health has announced that its levothyroxine tablet hypothyroidism treatments, Forthyron 200 and Forthyron 400, are now available in a scored snap-tab format that allows the tablet to be broken easily into four equal pieces.
Eurovet says this represents a significant benefit to practices, as individual patients often require varying doses due to differences in absorption and metabolism, requiring a wide variety of strengths of medication to be kept in stock. The new presentation means that veterinary surgeons can provide the accurate, customized, individualised approach that these patients require and since just two strengths need to be stocked, it is easier to manage the dispensary. This saves the practice time and money.
Forthyron contains levothyroxine, a synthetic product, chemically identical to naturally occurring T4 that, due to its long duration of action, is a commonly used treatment for hypothyroidism in dogs.
For further information telephone 01223 257933 or email office@eurovet-ah.co.uk www.eurovet-ah.co.uk
Chris, who is moving from Willows, will develop both the medical cardiology service and deliver a new interventional cardiology service to complement the existing surgical offering at Paragon, which is investing around £145,000 in ultrasound equipment and operating facilities to support the service.
Chris said: “I’ve had a great time at Willows and couldn’t think of a better place than Paragon to continue my passion for all things cardiology.
“It’s an exciting time to be joining Paragon, which is growing phenomenally to service the region whilst it cements itself as one of the leading referral centres in the north of England.
“The investment and expansion which is taking place at Paragon will allow us to develop another globally-recognised cardiology centre within Linnaeus.”
For more information, visit: www.paragonreferrals.co.uk
The expert panel consisted of Peter Sandøe (Denmark), Professor of Ethics and Welfare; Helle Friis Proschowsky (Denmark), a veterinary surgeon working with the Danish Kennel Club; Laurent Findji (France/UK), Specialist in Soft Tissue Surgery; Gudrun Ravetz (UK) – Senior Vice President, British Veterinary Association; Kristin Wear Prestrud (Norway) – Veterinary Scientific Director of the Norwegian Kennel Club and Åke Hedhammar (Sweden), Professor Emeritus in Internal Medicine (companion animals), a veterinary consultant for the Swedish Kennel Club and a member of the WSAVA Hereditary Disease Committee.
Kristin Wear Prestrud said: "Vets should dare to speak out. We must educate owners on all health and welfare matters, whether we are simply advising them that their dog is overweight or if we need to give advice on breeding or refuse planned Caesarean sections."
The panel's recommendations are:
At a practice level, veterinary professionals should:
At an organisational level, the veterinary profession should:
Photo: ponpimonsa_bibi/Shutterstock
The RCVS's new Royal Charter has come into effect today, meaning that the whole of the veterinary nursing profession in the UK is now regulated.
The new Charter received the Great Seal of the Realm and was collected from the House of Lords by RCVS Registrar Gordon Hockey and Policy Consultant Jeff Gill (pictured right). It had previously been approved at a meeting of the Privy Council on 5 November 2014.
Under the changes instituted in the new Charter, there are no longer listed veterinary nurses and all those formerly on the List have effectively been moved to the Register and become RVNs.
As a result they will now be expected to undertake the minimum requirement for continuing professional development (CPD) of 45 hours over a three-year period, will need to follow the RCVS Code of Professional Conduct for Veterinary Nurses,and will be subject to the College’s disciplinary system in cases of serious professional misconduct. Any veterinary nurse removed or suspended from the Register will not be entitled to give medical treatment or carry out minor surgery.
Gordon said: “This is a proud day for us and an important day for the profession as a whole. We worked very hard to get to this point and I would like to thank all those who helped us along the way including RCVS and VN Council members, College staff and the members of the profession and representative organisations, in particular the BVA and BVNA, that responded to our consultation on the proposed Charter last year.
“This Charter clarifies the role of the College and its aims and objectives while also modernising many of our regulatory functions. This represents another significant step towards the College becoming a first rate regulator.
“Critically, this Charter fulfils one of our long-term ambitions to create a coherent regulatory system for veterinary nurses and to recognise them as true professionals, dedicated to their vocation, their development and proper conduct.”
During this year’s renewal period for veterinary nurses (in the autumn), those formerly on the List will be expected to confirm that they are undertaking CPD and will also need to disclose any criminal convictions, cautions or adverse findings when they renew their registration. The annual renewal fee for veterinary nurses remains unchanged.
A detailed set of frequently asked questions for former listed veterinary nurses can be found at www.rcvs.org.uk/rvn.
Dechra says the ability to split Prednicortone into 1.25 mg doses is particularly useful when used alongside Zycortal, the only licensed treatment for canine Addison’s disease in Europe.
Dechra Brand Manager Carol Morgan said: "Dogs with primary Addison’s disease have insufficient levels of natural mineralocorticoids (primarily aldosterone) and glucocorticoids (primarily cortisol). Zycortal contains DOCP, a synthetically produced steroid hormone, which acts in a similar way to aldosterone.
"It causes sodium retention and potassium excretion, helping to maintain water balance but Zycortal only replaces the mineralocorticoid. Therefore, a daily oral glucocorticoid treatment, such as Prednicortone, is needed to address the cortisol deficiency, alongside Zycortal.
"The amount of glucocorticoid administered should be adjusted to the individual dog’s need and it is likely that the dose required will be reduced over time."
She added that a combined approach of Zycortal and Prednicortone allowed independent dose titration of both mineralocorticoids and glucocorticoids.
"The advantage of prescribing the two treatments is that the dosage for each component can be tailored to an individual animal’s response. This leads to a reduction in the side effects usually associated with over-supplementation of glucocorticoids."
There are 250 tablets in a pack and Prednicortone offers accurate dosing using a double divisible SmartTab format and accurate dispensing via blister packs. The flavoured tablets also encourage easy oral administration.
For more information, visit www.dechra.co.uk.
With at least 65% of dogs and 39% of cats reported as overweight (1&2), the competition is designed to promote a healthy body shape for cats and dogs, and reward the hard work of pet owners and veterinary nurses for achieving and maintaining a pet’s healthy weight. It is open to patients that are starting out on a weight loss programme, those maintaining a healthy body shape following weight loss and even those who have always been a healthy weight and shape.
Six finalists will be selected from all the entries and invited to attend an awards lunch where the overall winner will be announced. All finalists will receive a £100 shopping voucher and the overall winner will receive a £1000 holiday voucher.
Caroline Burke, Weight Management Specialist at Royal Canin said: "The Healthy Weight Competition is the perfect opportunity for veterinary nurses and owners to tackle this serious disease and prevent it occurring.
"There are many health issues associated with an animal being overweight as well as affecting quality of life, longevity and the welfare of the pet. The Healthy Weight Competition is an ideal opportunity for practices to identify the overweight patients, enrol them on a weight loss programme and enter the competition. It also enables them to reward those cats and dogs who have maintained an ideal body shape and weight over a period of time."
The competition is open until 31st of August 2018.
For more information, visit: www.royalcaninhealthyweight.co.uk or contact your Veterinary Business Manager.
Reference
Henry, who works at Crowshall Veterinary Services in Norfolk, graduated from the Royal Veterinary College in 2018.
He is the lead products export vet for Crowshall and was instrumental in the business’s preparation for Brexit.
He is also one of the founding ‘green champions’ at the practice, which has become the first specialist poultry practice to be accredited with Investors in the Environment.
The panel of seven judges from said that within just three years Henry has gained much experience, showing evidence that he has contributed to reduced antibiotic usage as well as improved biosecurity and improved bird welfare, health and production for his clients.
They said: “He has clearly shown he has worked with colleagues as a team, and has introduced new initiatives in his practice including improving mental health of staff and assisting in sustainability.”
James Porritt, National Pig and Poultry Sales Manager of award sponsors Zoetis, said all three finalists were very strong candidates: “It was great to see the work they have all done recognised at the awards.
"It was fantastic to see Henry win and hope the award spurs him on to continue his bright future in the poultry industry.”
Photo: Henry Lamb holding the Young Farm Vet trophy, alongside Jonathan Agnew (left) and James Porritt of the award sponsors Zoetis
Merial Animal Health has been found in breach of the NOAH Code of Practice for literature promoting the wormer Ivomec Super.
In the literature, Merial stated that Closantel injection (Janssen Animal Health) was effective against flukes aged 9 weeks or older, when in fact, at the time the undated brochure was distributed, Closantel was effective against flukes aged 7 weeks or older.
Merial did not dispute the facts alleged: the company had relied on an out-of-date detailer. The NOAH Code of Practice Committee emphasised the need for members to ensure, when giving comparative data in promotions, that up-to-date data is used. The SPC of any authorised product can be viewed on the VMD's website.
The Committee did commend Merial Animal Health for taking corrective action within two days of notification by the Complainant.
NOAH encourages those interested in finding out more to read the full details of the Committee's rulings on the NOAH website at www.noah.co.uk/code.
Nutraflex contains turmeric curcumin complex and boswellia extract, which Nutravet says work synergistically to support the natural systems that control inflammation.
The new product also contains glucosamine, a structural component of cartilage, and chondroitin sulphate to help maintain synovial fluid viscosity.
Nutravet claims the new product is fast acting, soothes stiff joints, aids long-term mobility, flexibility and joint structure, and supports the natural systems that control inflammation.
Chris Jones, Director at Nutravet said: “We’re delighted to be adding Nutraflex to our market-leading range of natural health products for pets.
"We’re always looking at ways of improving our products and Nutraflex provides our authorised stockists with a high strength veterinary exclusive joint support, supported by independent trial data, which works quickly to ultimately help pets that are suffering with joint stiffness.”
Nutraflex is available to order exclusively to authorised veterinary practices.
For more information, contact Nutravet on 0845 604 1688, email info@nutravet.co.uk or visit www.nutravet.com.
The BSAVA has launched a series of client information sheets for drugs commonly used off-label.
The information sheets were the brainchild of Professor Ian Ramsey, Editor-in-Chief of the BSAVA Small Animal Formulary. He said: "As a referral vet I write a lot of letters to owners and vets that include instructions about the drugs that I am prescribing or dispensing for a patient. Often these drugs are unusual or cytotoxic, and are very commonly only authorized for human patients. As Editor of the Formulary I am acutely aware of the responsibility that I have for making sure owners understand what these drugs are for and what the side effects might be."
The BSAVA says it hopes the leaflets will overcome the challenge veterinary surgeons have in remembering all the drug information that needs to be related to clients, and the problem of clients forgetting what they have been told verbally by the clinician during a consultation.
In addition to a basic introduction to the Prescribing Cascade, each of the client leaflets provides the following information:
The first batch of client information leaflets, which relate to the following medications prescribed for dogs and cats, is now available for members to download from the BSAVA website (http://www.bsava.com/):
Each of the leaflets has a space for veterinary practices to add their details before distributing them to their clients, and the BSAVA says more may be added during 2011.
This is the first confirmed finding of the virus in the UK this winter and tests have shown it is closely related to the H5N6 strain that has been circulating in wild birds across Europe in recent months. This is different to the strains which affected people in China last year and Public Health England have advised the risk to public health is very low. The Food Standards Agency have said that bird flu does not pose a food safety risk for UK consumers.
UK Chief Veterinary Officer, Nigel Gibbens, said: "This is the first time avian flu has been identified in the UK this winter and while the disease does not represent a threat to the public, it is highly infectious and deadly to birds.
"As the virus has been circulating across Europe, this finding has not come as a surprise. But it is vital that anyone who keeps birds - whether a few in a back garden or thousands on a farm - is vigilant for any signs of disease, reports suspect disease to APHA and maintains good biosecurity to reduce the risk of their birds becoming infected."
Local measures will be put in place to manage the potential threat. These include a local Avian Influenza Prevention Zone (AIPZ) in Dorset as a precautionary measure to prevent disease spread to other birds. This means all captive bird keepers in the area will have to implement enhanced biosecurity measures such as feeding and watering birds undercover so that wild birds do not co-mingle with kept birds; minimising movement in and out of bird enclosures; cleaning and disinfecting footwear; and keeping areas where birds live clean and tidy.
There are no plans for culling or movement restrictions.
BVA President John Fishwick said: "I’d encourage vets to reassure their clients that this strain of Avian Influenza poses a very low risk to public health and the food chain. Defra have acted swiftly to try and contain further spread of the disease, which has likely come from migratory birds, yet vets and poultry owners should remain vigilant for signs of the disease."
British Veterinary Poultry Association (BVPA) President Phil Hammond added: "It’s really important that all bird keepers heed biosecurity advice issued by Defra, and maintain the highest biosecurity standards. Any suspicion of Avian Influenza should be reported to the APHA as soon as possible."
Up-to-date advice and guidance on Avian Influenza is available on the Gov.UK website, including how to spot it, what to do if you suspect it, and measures to prevent it: https://www.gov.uk/guidance/avian-influenza-bird-flu#about-avian-influenza
For further advice on Avian Influenza contact the Defra Helpline on 03459 33 55 77.
Trade should not be affected following the findings in wild birds, according to the rules of the World Animal Health Organisation (OIE).
Photo: Wild Birds, Shutterstock / aDam Wildlife
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and ProteqFlu Te.
In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.
The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted2.
Elanco also highlights a recent study3 which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination. This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.
References:
If you are speaking at or hosting a small animal CPD event in 2019, please email details to press@vetsurgeon.org for it to be considered for addition to this list.
This list includes events from CPD Solutions, Improve International, the Veterinary Poisons Information Service and the Small Animal Medicine Society.
RVC researchers say that the VetCompass study is the largest ever carried out into dental disease in cats using veterinary clinical records.
The study investigated a sample of 18,249 cats randomly selected from a study population of 1,255,130 cats in the UK in 2019.
Periodontal disease was recorded in 15.2% of the sample making it the most common disorder.
The cat breeds with the highest annual levels of this diagnosis were Siamese (18.7%), Maine Coon (16.7%) and British Short Hair (15.5%) as well as crossbreeds (15.4%).
The average bodyweight of cats with periodontal disease (5.7kg) was higher than for cats without periodontal disease (5.5kg).
The risk of periodontal disease rose steeply as cats got older, with cats aged 9 to 12 years being 6.7 times more likely to have periodontal disease compared with cats aged under 3 years.
Cats with periodontal disease were much more likely to have a range of other health conditions compared to cats without periodontal disease (x 1.8 risk).
These conditions included cardiac dysrhythmia (x 2.3 risk), ear discharge (x 2.3 risk) and hairball/furball (x 2.3 risk).
The researchers say that these findings suggest that periodontal disease should be acknowledged as a leading health and welfare issue in cats, and highlight the need for greater dental care in cats as they age.
The study was supported by an award from the Kennel Club Charitable Trust and Agria Pet Insurance.
Anna, who has been with the Hertfordshire-based referral centre for seven years, is now an RCVS, EBVS and American Specialist in Small Animal Internal Medicine.
She graduated from The University of Liverpool in 2007 and spent four years working in general practice in Kent.
She then went on to complete a rotating internship, followed by a residency in Small Animal Internal Medicine at the Royal Veterinary College where she gained her Master’s degree and Diploma.
Whilst enjoying all aspects of Internal Medicine, she has special interests in endocrinology and haematology. The latter, combined with her love for cats, has fuelled her interest in feline transfusion medicine.
Anna said: “I am delighted to have been appointed as Head of Internal Medicine at Davies.
“The Internal Medicine team are the detectives who work to establish a diagnosis, and we often have the added bonus of working closely with other disciplines in our multi-disciplinary environment.
"It is a challenging and highly rewarding service, with a wide variety of cases and I am delighted to work with a first-class team of clinicians and nurses.”
For the study, researchers from the RVC’s VetCompass Programme identified 2,105 hypothyroidism cases diagnosed amongst a study population of 905,553 UK dogs.
This revealed an annual frequency of one case in 400 dogs (0.23%) for the condition, with the most common breeds diagnosed being Standard Doberman Pinschers (x 17.02), Tibetan Terriers (x11.25), Boxers (x10.44) and Alaskan Malamutes (x 9.71).
The average age at first diagnosis was 7.65 years.
Other findings included:
Dr Rebecca Geddes, Lecturer in Small Animal Internal Medicine at the RVC Queen Mother Hospital for Animals and last author of the paper, said: “It is great to have this data from UK primary care practices, which will help highlight high risk breeds to veterinary surgeons so they can diagnose and treat affected dogs as early as possible. Hypothyroidism is usually straightforward to manage with medication that can greatly improve quality of life in affected dogs.”
The BVA Voice of the Veterinary Profession research found the most cited welfare issue facing exotics was ‘irresponsible animal ownership’ (82%).
Vets who treat NTCAs reported that 58% of the NTCAs they see do not have their five animal welfare needs met and 26% have seen a rise in the number brought in for treatment in the past year.
BVA Senior Vice President and zoo veterinary surgeon Justine Shotton said: “The welfare of non-traditional companion animals has long been a concern of many vets and this is demonstrated in our recent research.
"It is worrying that a quarter of vets are seeing an increase in the number brought in for treatment and sad to hear that so many cite irresponsible ownership as the top cause behind welfare issues.
"We know people who keep these animals have the right intentions to give them best care they can but their needs are so complex it can be difficult to do so, particularly if they are a new pet and owners are not sure exactly what they need.
"It is so important that potential buyers give careful consideration to buying such an animal before bringing one home.
"We’d also urge any vets who are approached by potential keepers for advice to strongly encourage them to do their research to ensure they have the skills and knowledge to care for them properly before buying an exotic species.”
BVA's new policy position calls for more regulation of online sales and third-party advertising of NTCAs and an end to the import of wild-caught reptiles and amphibians for non-conservation reasons.
BVA also recommends a pre-purchase test, both demonstrating a potential owner’s knowledge on how to properly care for an NTCA, and helping to improve education around the needs of the species.
Past BVA President and Chair of the Working Group Sean Wensley said: “The new policy position makes recommendations which will help to protect the welfare of NTCAs, including calling for improved regulation of their keeping and sale.
"It highlights issues such as the welfare risks of certain breeding practices and stresses the need to move away from the wild-capture of animals for the pet trade.
"Taken together, the 32 recommendations present a clear veterinary view on the ethical sourcing and care of these species.”
www.bva.co.uk/exoticpets
The CMA proposed that veterinary practices should be compelled to:
Most of these, along with the CMA's support for reform of the Veterinary Surgeons Act, have been welcomed not just by the BVA, but by the RCVS and the BVNA which also issued their responses on Friday.
The big sticking points, however, are the proposal that veterinary practices should cap prescription fees at £16, and that all practices should inform clients that they may buy medicines cheaper online.
The BVA argued that the proposed prescription price cap would be unlikely to reduce costs, and that 65% of vets who took part in its Voice of the Profession Survey said it would risk practice viability.
The proposal that vets should tell clients they can buy medicines cheaper online was more controversial, because of course two of the largest veterinary pharmacies are owned by corporate groups, and it is hard to think of any other area of business where small companies are legally required to direct customers to their corporate competitors.
BVA President Dr. Rob Williams MRCVS (pictured) said: “The measures outlined in the CMA’s provisional decision report are much more measured and proportionate compared to earlier proposals and that clearly shows they have listened to our concerns.
"As vets, we welcome the measures that increase transparency and help us to better support our clients.
"However, it’s vital that the CMA gets the detail right or it risks unintended negative consequences.
“BVA particularly welcomes the CMA backing our calls for reform of the outdated Veterinary Surgeons Act, including the need for practice regulation.
"Vets have been pressing for reform of this woefully outdated legislation for many years, and reform will go a long way to addressing many of the concerns raised throughout the CMA investigation and will help build trust with our clients.
“We do, however, have serious concerns about the medicines proposals – it is simply unreasonable to expect vet practices to actively promote online pharmacies, which are in direct competition for customers and some of which are run by large veterinary groups.
"In addition, the proposed £16 price cap for prescriptions will be ineffective and is unlikely to lead to lower vet bills for consumers.”
https://www.bva.co.uk/media/6641/bva-bsava-bvna-spvs-vmg-joint-response-to-cma-provisional-decision-report-final.pdf
Practices will be able to offer customers increased support for their worming programmes in 2010, as part of a new initiative from Eqvalan® manufacturer, Merial.
Eqvalan product manager Claire Edmunds said: "The SMART worming campaign is designed to encourage owners to Simply Monitor, Assess Risk and, if necessary, Treat with the most appropriate wormer.
"We know that worming can be confusing for horse owners, so the SMART approach is designed to help them manage their worming programmes more easily, whilst also ensuring that wormers are used in a way that may help prevent the development of resistance.
Practices purchasing Eqvalan Duo during February and March can get 4 tubes free when they purchase 20. In addition, to kick start the SMART campaign for each order on the above offer, Merial will supply 20 free Worm Egg Count vouchers worth £10/€10 each. For those practices with their own testing facilities, the company is also offering promotional support to help encourage increased uptake and client buy-in.
Claire added: "As well as continuing with the successful free worm egg count campaign available for practices during February and March, owners will also have access to a personalised on-line planner, as well as text and email alerts.
"The campaign is being supported with new point of sale material and a prominent consumer advertising campaign. In addition we also have an extensive VN SQP CPD training programme planned for 2010.
"With the consensus of expert opinion on the future of worming firmly behind the use of targeted programmes incorporating worm egg counts, there has never been a more important time to get closer to clients and help them with their worming strategies."
If you would like further information, please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.
Dechra says it expects Osphos to change the way chronic lameness caused by navicular syndrome is tackled by equine vets.
According to the company, clinical trials of Osphos showed 74.7% of horses experienced improvement by at least one lameness grade at 56 days post treatment.
Dechra brand manager Emma Jennings said: "Osphos intramuscular injection contains the bisphosphonate clodronic acid which inhibits resorption in the navicular bone by binding to hydroxyapatite crystals and by direct cellular effects on osteoclasts.
"We are delighted with the results of the trials, which proved that Osphos is effective at 6 months post-treatment. We're looking forward to being able to support equine vets, vet nurses and practices by providing an intramuscular Clodronic acid injection for horses."
Dechra also says studies showed that mild transient colic was seen following just 1.6 per cent of treatments.
Osphos 60 mg/ml solution for injection for horses is available from September 2014.
The Forestry Commission, together with other agencies and landowners, is stepping up efforts to find out why some dogs have fallen ill while on countryside walks.
Over 50 cases of so called Seasonal Canine Illness (SCI) occurred during the autumn of 2009 and 2010 in Nottinghamshire, Lincolnshire, East Anglia and Warwickshire, although there have been reports from further afield.
Symptoms include severe vomiting, diarrhoea, shaking / trembling and high temperature, and have generally been displayed by animals within 24 hours of walking in the countryside, especially in woodlands. A small number of dogs have died. The cause of Seasonal Canine Illness remains unknown.
Jo Atkinson, from the Forestry Commission, said: "Although no cases have yet been reported this year, we are working with our many partners to get a clearer picture of the distribution and reasons behind this upsetting sickness. Both dog owners and vets can play their part too in helping protect cherished pets."
Moves to tackle the illness include:
Veterinary surgeons are asked to: